GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Price-to-Funds-From-Operations

Pangen Biotech (XKRX:222110) Price-to-Funds-From-Operations : (As of Jun. 04, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Pangen Biotech (XKRX:222110) Business Description

Traded in Other Exchanges
N/A
Address
4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.